Voloridge Investment Management
MYOK

Voloridge Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Voloridge Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-44,491
Closed -$4.3M – 1584
2020
Q2 		$4.3M Buy
44,491
+9,444
+27% +$788K 0.05% 391
2020
Q1 		$1.64M Buy
35,047
+3,627
+12% +$232K 0.05% 396
2019
Q4 		$2.29M Buy
+31,420
New +$1.91M 0.04% 458
2019
Q2 		– Sell
-19,302
Closed -$1M – 1210
2019
Q1 		$1M Buy
+19,302
New +$889K 0.03% 474

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Voloridge Investment Management's MYOK Position: Q3 2020 in Review

Voloridge Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 44,491 shares — an estimated $4.3M sold.

Voloridge Investment Management first reported a position in MYOK in Q1 2019 and held it in 4 quarters. The position peaked at $4.3M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Voloridge Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 44,491 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $4.3M.
  • Voloridge Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • Voloridge Investment Management's MyoKardia, Inc. Common Stock position peaked at $4.3M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Voloridge Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.